Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA)
Clinical trial NCT03492658 · COMPLETED
Trial details
- NCT number
- NCT03492658
- Sponsor
- Leiden University Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-17
- Primary completion
- 2021-10-26
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.